Senyo Health App - Comorbid Substance Use Disorder Treatment In Bipolar Patients Using A Telehealth Collaborative Care Platform
Mayo Clinic
Summary
The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving substance use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * History of bipolar I disorder, bipolar II disorder, or schizoaffective disorder of the bipolar type * Alcohol use disorder. * Ability to read, write, and understand English; * Minimum DAST (1+) or AUDIT-C score (3+) * Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care; * Eligibility determined by ASAM Assessment Exclusion Criteria: * Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psych…
Interventions
- OtherSenyo Health App
The Senyo Health app includes asynchronous cognitive behavioral therapy (CBT) modules, contingency management, behavioral activation, and an interface to interact with the care manager for support in treating the comorbidities of bipolar disorder and substance use disorder. Patients will engage with the app daily and have weekly check-in visits with the care manager. After the initial 12 week intervention phase, subjects will be followed for 1 year.
Location
- Mayo Clinic in RochesterRochester, Minnesota